Related Experiment Video
Updated: Jan 28, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular
Shanqiang Qu1,2,3,4, Qiuming Pan1,2,3,4, Xin Zhang3,5
1Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, The People's Republic of China.
Purpose:
Gliomas represent the second most common malignancy and leading cause of cancer death in adolescents and young adults (AYA; ages 15-39 years), yet their molecular landscape remains incompletely characterized. This study aims to characterize the molecular landscape of primary gliomas in AYAs by integrating multi-omics data.
Experimental Design:
We recruited a cohort of patients with histopathologically diagnosed primary gliomas. The data encompassed clinical, imaging, histopathologic, genomic testing, and survival outcome data. The correlations of clinicopathologic features, molecular characteristics, and anatomic heterogeneity with prognosis were evaluated.
Results:
Adult-type gliomas (66.2%) predominated, but pediatric-type gliomas constituted 23.6%, exhibiting distinct clinicopathologic profiles: pediatric-type tumors harbored frequent H3.3 (51.9%), TP53 (35.1%), and BRAF mutations (22.8%), whereas adult-type showed isocitrate dehydrogenase (IDH, 72.5%) and TP53 alterations (48.6%). IDH and H3.3/BRAF mutations were mutually exclusive. Anatomically, midline involvement (18.3%) correlated with younger age (≤25 years, P = 0.019), frontal gliomas were predominantly IDH mutations (58.3%), and midline tumors were enriched H3.3 K27M mutations (52.5%). Survival analysis revealed that H3.3 K27M-mutant high-grade gliomas had the poorest prognosis (median survival: 16 months), whereas BRAF-driven low-grade gliomas showed favorable outcomes. Pediatric-type molecular alterations are enriched in AYA gliomas. IDH wild-type tumors require sequencing to detect pediatric-type drivers (e.g., H3.3/BRAF mutations).
Conclusions:
The treatment strategies for AYA gliomas should be determined by molecular classification rather than age-based stratification. Adult-type and pediatric-type gliomas exhibit distinct biological and driver profiles. AYA gliomas exhibit significant molecular-anatomic heterogeneity, with specific anatomic regions demonstrating enrichment of molecular signatures.
Insights
Adolescent and young adult (AYA) gliomas show distinct molecular profiles, with pediatric-type alterations prevalent. Molecular classification, not age, should guide AYA glioma treatment strategies for better outcomes.
Area of Science:
- Neuro-oncology
- Molecular pathology
- Genomics
Background:
- Gliomas are a significant cause of cancer death in adolescents and young adults (AYA).
- The molecular landscape of AYA gliomas is not fully understood.
- Understanding these molecular differences is crucial for targeted therapies.
Purpose of the Study:
- To characterize the molecular landscape of primary gliomas in AYA patients.
- To integrate multi-omics data for comprehensive analysis.
- To identify distinct molecular profiles between adult-type and pediatric-type gliomas in AYA.
Main Methods:
- Recruitment of patients with histopathologically diagnosed primary gliomas.
- Collection of clinical, imaging, histopathological, and genomic data.
- Evaluation of correlations between clinicopathological features, molecular characteristics, anatomical heterogeneity, and prognosis.
Main Results:
- Adult-type gliomas predominated (66.2%), but pediatric-type gliomas were also present (23.6%).
- Pediatric-type gliomas showed frequent H3.3, TP53, and BRAF mutations, while adult-type had IDH and TP53 alterations.
- H3.3 K27M-mutant high-grade gliomas had the poorest prognosis (16 months median survival), while BRAF-driven low-grade gliomas had favorable outcomes.
Conclusions:
- Molecular classification, not age, should guide treatment strategies for AYA gliomas.
- Adult-type and pediatric-type gliomas in AYA patients have distinct biological and driver profiles.
- Significant molecular-anatomical heterogeneity exists in AYA gliomas, with specific regions enriched for molecular signatures.
Related Concept Videos
The Evidence for Evolution
Revisionist Views of Adolescent and Adult Cognition
Chemical Equilibria: Redefining Equilibrium Constant
To calculate the equilibrium constants of solutions of moderately high ionic strength, one must account for the salt effect. This redefined...
Cognitive Development During Adolescence
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...
Cardiovascular Drugs: Classification based on Therapeutic Indications

